2012 annual financial data
Coherus Oncology 2012 Operating cash flow margin
Direct answer
Operating cash flow margin was -961.08%.
Operating income was -38,518,000 USD and net income was -33,018,000 USD.
Operating cash flow was -18,251,000 USD.
Get free Coherus Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,899,000 USD
- Operating income
- -38,518,000 USD
- Net income
- -33,018,000 USD
- Operating cash flow
- -18,251,000 USD